News
Now, let’s get to the juicy part. In a dataset that goes back to January 2019, the 4-6-U sequence has flashed 13 times on a ...
Q2 earnings are scheduled to be released on August 7, after market close. The pharma company is expected to post an EPS of $1 ...
StockStory.org on MSN18h
Gilead Sciences (GILD) Reports Q2: Everything You Need To Know Ahead Of EarningsBiopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be reporting results this Thursday after market close. Here’s ...
Analysts expect Gilead Sciences to report an earnings per share (EPS) of $1.95. Investors in Gilead Sciences are eagerly ...
The stock's fall snapped a two-day winning streak.
This was the stock's second consecutive day of gains.
Gilead Sciences, Inc. has announced that it has received new approval from the U.S. Food and Drug Administration (FDA) for a ...
Despite decades of medical progress, HIV continues to devastate Black communities. The statistics are sobering. The disparities, undeniable.
The largest group of Black physicians, thought leaders, and celebrities were in one room to have a needed discussion about HIV.
AbbVie, Gilead Sciences and GSK marked World Hepatitis Day on Monday, outlining the need to tackle the stigma and ...
An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...
Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black women-serving organizations in the U.S. since 2010, with $28 million granted to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results